Prostate Cancer - Results from #26220

Narrow safety range of intraoperative rectal irradiation exposure volume for avoiding bleeding after seed implant brachytherapy - Abstract March 16, 2012

Emerging novel therapies for advanced prostate cancer - Abstract March 16, 2012

Tissue biomarkers for prostate cancer radiation therapy - Abstract March 15, 2012

Complications and functional results of surgery for locally advanced prostate cancer - Abstract March 15, 2012

Risk factors for the onset of prostatic cancer: Age, location, and behavioral correlates - Abstract March 15, 2012

Abiraterone acetate: Oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer - Abstract March 15, 2012

Improvement in prostate cancer survival over time: A 20-year analysis - Abstract March 15, 2012

Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy - Abstract March 14, 2012

Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy - Abstract March 14, 2012

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer - Abstract March 14, 2012

Increased non-prostate cancer death risk in clinically diagnosed prostate cancer - Abstract March 14, 2012

Docetaxel in the treatment of metastatic castration-resistant prostate cancer (mCRPC): An observational study in a single institution - Abstract March 14, 2012

CD10 is inversely associated with nuclear factor-Kappa B and predicts biochemical recurrence after radical prostatectomy - Abstract March 13, 2012

Imaging in prostate cancer staging: Present role and future perspectives - Abstract March 13, 2012

Effects of physical activity on cancer risk and disease progression after cancer diagnosis - Abstract March 13, 2012

Third-generation salvage cryotherapy for radiorecurrent prostate cancer: A centre's experience - Abstract March 13, 2012

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer - Abstract March 13, 2012

High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: A 7-year experience - Abstract March 12, 2012

Patients and partners lack knowledge of androgen deprivation therapy side effects - Abstract March 12, 2012

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial - Abstract March 12, 2012

Page 1312 of 1437